knowledge -WSS

knowledge

author：entertainment 2025-10-01 14:16:10 - browse：5875

Blood samples — Marion Berard/AFP/GettyImages

With the advent of disease-modifying Alzheimer’s drugs, everyone in the world of Alzheimer’s diagnostics is bracing for the crush.

Based on their ability to slow cognitive decline, the Eisai/Biogen drug Leqembi won full approval from the FDA this month, and donanemab by Eli Lilly could be approved by year end. Clinicians now have to decide which patients are most suitable for treatment, which means better Alzheimer’s tests need to be developed.

“There’s going to be capacity issues because there’s just not enough neurologists in the world to treat this pool of patients with Alzheimer’s disease at the moment,” said Mark Stearman, a senior international product manager at Roche focusing on Alzheimer’s diagnostics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： TytoCare raises $49 million to build out AI

WSS

Dramatically reducing cancer deaths requires the PASTEUR Act

Stem cell clinics for heart failure: buyer be wary

What Mike Pence has said that could be used in a Donald Trump trial

Surprise medical billing ban raises prices elsewhere

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Hospitals are piloting generative AI tools as regulators play catch

hotspot

knowledge

explore

Hepatitis C has a cure — but many Americans still lack access to it

FDA warns medical device makers about rise in fabricated data

Activists slam private health insurers over coverage restrictions

FDA warns medical device makers about rise in fabricated data

Continuity nursing helped my family in our darkest PICU moments

Verily hires former Apple Health leader as chief scientific officer

Supreme Court strikes down use of affirmative action

Humana, CVS hope to turn members into patients at clinics

BioMarin wins approval for gene therapy to treat hemophilia A

WATCH: Why do our ears pop?

Wikipedia

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

ER docs worry over extreme heat as a 'mass casualty event'

Surprise medical billing ban raises prices elsewhere

Reporting on presidential health from Reagan to Trump and Biden

hotspot

knowledge

entertainment

hotspot